Trademark Overview
On Thursday, September 26, 2024, a trademark application was filed for LUMAVERE with the United States Patent and Trademark Office. The USPTO has given the LUMAVERE trademark a serial number of 98771598. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 26, 2024. This trademark is owned by Axsome Therapeutics, Inc.. The LUMAVERE trademark is filed in the Pharmaceutical Products category with the following description:
Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss.
